CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.

Current thinking emphasizes the primacy of CD14 in facilitating recognition of microbes by certain TLRs to initiate pro-inflammatory signaling events and the importance of p38-MAPK in augmenting such responses. Herein, this paradigm is challenged by demonstrating that recognition of live Borrelia bu...

Full description

Bibliographic Details
Main Authors: Bikash Sahay, Rebeca L Patsey, Christian H Eggers, Juan C Salazar, Justin D Radolf, Timothy J Sellati
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-12-01
Series:PLoS Pathogens
Online Access:http://europepmc.org/articles/PMC2781632?pdf=render
_version_ 1829138869095759872
author Bikash Sahay
Rebeca L Patsey
Christian H Eggers
Juan C Salazar
Justin D Radolf
Timothy J Sellati
author_facet Bikash Sahay
Rebeca L Patsey
Christian H Eggers
Juan C Salazar
Justin D Radolf
Timothy J Sellati
author_sort Bikash Sahay
collection DOAJ
description Current thinking emphasizes the primacy of CD14 in facilitating recognition of microbes by certain TLRs to initiate pro-inflammatory signaling events and the importance of p38-MAPK in augmenting such responses. Herein, this paradigm is challenged by demonstrating that recognition of live Borrelia burgdorferi not only triggers an inflammatory response in the absence of CD14, but one that is, in part, a consequence of altered PI3K/AKT/p38-MAPK signaling and impaired negative regulation of TLR2. CD14 deficiency results in increased localization of PI3K to lipid rafts, hyperphosphorylation of AKT, and reduced activation of p38. Such aberrant signaling leads to decreased negative regulation by SOCS1, SOCS3, and CIS, thereby compromising the induction of tolerance in macrophages and engendering more severe and persistent inflammatory responses to B. burgdorferi. Importantly, these altered signaling events and the higher cytokine production observed can be mimicked through shRNA and pharmacological inhibition of p38 activity in CD14-expressing macrophages. Perturbation of this CD14/p38-MAPK-dependent immune regulation may underlie development of infectious chronic inflammatory syndromes.
first_indexed 2024-12-14T19:25:19Z
format Article
id doaj.art-b6a4410be62b4ddd9a351c03a3c4c722
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-12-14T19:25:19Z
publishDate 2009-12-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-b6a4410be62b4ddd9a351c03a3c4c7222022-12-21T22:50:12ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742009-12-01512e100068710.1371/journal.ppat.1000687CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.Bikash SahayRebeca L PatseyChristian H EggersJuan C SalazarJustin D RadolfTimothy J SellatiCurrent thinking emphasizes the primacy of CD14 in facilitating recognition of microbes by certain TLRs to initiate pro-inflammatory signaling events and the importance of p38-MAPK in augmenting such responses. Herein, this paradigm is challenged by demonstrating that recognition of live Borrelia burgdorferi not only triggers an inflammatory response in the absence of CD14, but one that is, in part, a consequence of altered PI3K/AKT/p38-MAPK signaling and impaired negative regulation of TLR2. CD14 deficiency results in increased localization of PI3K to lipid rafts, hyperphosphorylation of AKT, and reduced activation of p38. Such aberrant signaling leads to decreased negative regulation by SOCS1, SOCS3, and CIS, thereby compromising the induction of tolerance in macrophages and engendering more severe and persistent inflammatory responses to B. burgdorferi. Importantly, these altered signaling events and the higher cytokine production observed can be mimicked through shRNA and pharmacological inhibition of p38 activity in CD14-expressing macrophages. Perturbation of this CD14/p38-MAPK-dependent immune regulation may underlie development of infectious chronic inflammatory syndromes.http://europepmc.org/articles/PMC2781632?pdf=render
spellingShingle Bikash Sahay
Rebeca L Patsey
Christian H Eggers
Juan C Salazar
Justin D Radolf
Timothy J Sellati
CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.
PLoS Pathogens
title CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.
title_full CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.
title_fullStr CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.
title_full_unstemmed CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.
title_short CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCS-dependent tolerance.
title_sort cd14 signaling restrains chronic inflammation through induction of p38 mapk socs dependent tolerance
url http://europepmc.org/articles/PMC2781632?pdf=render
work_keys_str_mv AT bikashsahay cd14signalingrestrainschronicinflammationthroughinductionofp38mapksocsdependenttolerance
AT rebecalpatsey cd14signalingrestrainschronicinflammationthroughinductionofp38mapksocsdependenttolerance
AT christianheggers cd14signalingrestrainschronicinflammationthroughinductionofp38mapksocsdependenttolerance
AT juancsalazar cd14signalingrestrainschronicinflammationthroughinductionofp38mapksocsdependenttolerance
AT justindradolf cd14signalingrestrainschronicinflammationthroughinductionofp38mapksocsdependenttolerance
AT timothyjsellati cd14signalingrestrainschronicinflammationthroughinductionofp38mapksocsdependenttolerance